M | SD | 1—Lowest | 2 | 3 | 4 | 5—Highest | % | N | |
---|---|---|---|---|---|---|---|---|---|
Confidence level in medications assessments | 2.3 | 0.95 | 33 (26.40%) | 39 (31.20%) | 42 (33.60%) | 11 (8.80%) | 0 | ||
Level of importance of knowing the price of medication | 4.5 | 0.73 | 1 (0.80%) | 2 (1.60%) | 6 (4.80%) | 47 (37.60%) | 69 (55.20%) | ||
Price consideration | 3.9 | 0.97 | 1 (0.80%) | 11 (8.90%) | 27 (21.80%) | 47 (37.90%) | 38 (30.60%) | ||
Patient ability to purchase medications | 3.7 | 0.99 | 3 (2.40%) | 12 (9.60%) | 29 (23.20%) | 60 (48.005) | 21 (16.80%) | ||
Ease of access to information | 3.2 | 1.08 | 8 (6.50%) | 23 (18.50%) | 44 (35.50%) | 34 (27.40%) | 15 (12.10%) | ||
Source of information—patients | 77.4 | 96 | |||||||
Source of information—pharma companies | 56.5 | 70 | |||||||
Source of information—HMO funds | 33.9 | 42 | |||||||
Source of information—pharmaceutical networks | 29 | 36 | |||||||
Source of information—other | 10.5 | 13 |